Follow The Filings

PDSB PDS Biotechnology

PDS Biotechnology earnings company data as of 4:48 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS — -0.18 —
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 8.01,9.01
8-K 5.02,8.01,9.01
8-K 8.01,9.01
8-K 8.01,9.01
SCHEDULE 13D —
8-K 8.01,9.01
8-K 1.02,5.02,7.01,8.01,9.01
8-K 1.01,3.02,7.01,9.01
8-K 1.01,2.03,9.01
8-K 2.05,5.02
8-K 5.02
8-K 5.03,5.07,9.01
8-K 2.02,9.01
10-Q
8-K 7.01,9.01
8-K 3.01
424B4
DEF 14A
DEFA14A
8-K 8.01
8-K 1.01,1.02,2.03,3.02,3.03,9.01
424B5
8-K 8.01
10-Q
8-K 2.02,9.01

Insider forms

Forms 3, 4 and 5 from EDGAR, 3 rows shown

Filed Form Detail Links
4 Period Oct 18, 2026
4 Period Oct 18, 2026 (2 forms)
4 Period Jan 12, 2026 (2 forms)

4 more insider forms

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.